Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 208

1.

Removal of dabigatran by hemodialysis.

Chang DN, Dager WE, Chin AI.

Am J Kidney Dis. 2013 Mar;61(3):487-9. doi: 10.1053/j.ajkd.2012.08.047. Epub 2012 Dec 5.

PMID:
23219111
2.

Dabigatran overdose: case report of laboratory coagulation parameters and hemodialysis of an 85-year-old man.

Montaruli B, Erroi L, Vitale C, Berutti S, Cosseddu D, Sivera P, Coglitore R, Marangella M, Migliardi M.

Blood Coagul Fibrinolysis. 2015 Mar;26(2):225-9. doi: 10.1097/MBC.0000000000000221.

PMID:
25629417
3.

Extracorporeal therapy for dabigatran removal in the treatment of acute bleeding: a single center experience.

Singh T, Maw TT, Henry BL, Pastor-Soler NM, Unruh ML, Hallows KR, Nolin TD.

Clin J Am Soc Nephrol. 2013 Sep;8(9):1533-9. doi: 10.2215/CJN.01570213. Epub 2013 May 23.

4.

[Patient with acute renal injury presenting dabigatran overdose: Hemodialysis for surgery].

Bachellerie B, Ruiz S, Conil JM, Crognier L, Seguin T, Georges B, Fourcade O.

Ann Fr Anesth Reanim. 2014 Jan;33(1):44-6. doi: 10.1016/j.annfar.2013.11.011. Epub 2013 Dec 28. French.

PMID:
24378048
5.

Hemodialysis for the treatment of pulmonary hemorrhage from dabigatran overdose.

Chen BC, Sheth NR, Dadzie KA, Smith SW, Nelson LS, Hoffman RS, Winchester JF.

Am J Kidney Dis. 2013 Sep;62(3):591-4. doi: 10.1053/j.ajkd.2013.02.361. Epub 2013 Apr 16.

PMID:
23597859
6.

Safe use of hemodialysis for dabigatran removal before cardiac surgery.

Wanek MR, Horn ET, Elapavaluru S, Baroody SC, Sokos G.

Ann Pharmacother. 2012 Sep;46(9):e21. doi: 10.1345/aph.1R081. Epub 2012 Aug 7.

PMID:
22872748
7.

The acute management of haemorrhage, surgery and overdose in patients receiving dabigatran.

Alikhan R, Rayment R, Keeling D, Baglin T, Benson G, Green L, Marshall S, Patel R, Pavord S, Rose P, Tait C.

Emerg Med J. 2014 Feb;31(2):163-8. doi: 10.1136/emermed-2012-201976. Epub 2013 Feb 22. Review.

8.

[Hemodialysis to remove anticoagulant dabigatran during emergencies].

Carrizo A, Campbell S.

Medicina (B Aires). 2014;74(2):121-3. Spanish.

9.

Hemorrhagic complications associated with dabigatran use.

Chen BC, Viny AD, Garlich FM, Basciano P, Howland MA, Smith SW, Hoffman RS, Nelson LS.

Clin Toxicol (Phila). 2012 Nov;50(9):854-7. doi: 10.3109/15563650.2012.721888. Epub 2012 Sep 12.

PMID:
22970730
10.

Potential inaccuracy of point-of-care INR in dabigatran-treated patients.

Baruch L, Sherman O.

Ann Pharmacother. 2011 Jul;45(7-8):e40. doi: 10.1345/aph.1Q105. Epub 2011 Jun 28.

PMID:
21712509
11.

Comparison of intermittent and continuous extracorporeal treatments for the enhanced elimination of dabigatran.

Bouchard J, Ghannoum M, Bernier-Jean A, Williamson D, Kershaw G, Weatherburn C, Eris JM, Tran H, Patel JP, Roberts DM.

Clin Toxicol (Phila). 2015 Mar;53(3):156-63. doi: 10.3109/15563650.2015.1004580. Epub 2015 Feb 8.

PMID:
25661675
12.

Dabigatran and kidney disease: a bad combination.

Knauf F, Chaknos CM, Berns JS, Perazella MA.

Clin J Am Soc Nephrol. 2013 Sep;8(9):1591-7. doi: 10.2215/CJN.01260213. Epub 2013 Jul 18. Review.

13.

A case of dabigatran-associated acute renal failure.

Shafi ST, Negrete H, Roy P, Julius CJ, Sarac E.

WMJ. 2013 Aug;112(4):173-5; quiz 176.

14.

Hemorrhagic complications in emergency department patients who are receiving dabigatran compared with warfarin.

Berger R, Salhanick SD, Chase M, Ganetsky M.

Ann Emerg Med. 2013 Apr;61(4):475-9. doi: 10.1016/j.annemergmed.2013.02.008.

PMID:
23522810
15.

Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation.

Freeman JV, Zhu RP, Owens DK, Garber AM, Hutton DW, Go AS, Wang PJ, Turakhia MP.

Ann Intern Med. 2011 Jan 4;154(1):1-11. doi: 10.7326/0003-4819-154-1-201101040-00289. Epub 2010 Nov 1.

PMID:
21041570
16.

Use of continuous veno-venous haemodiafiltration therapy in dabigatran overdose.

Chiew AL, Khamoudes D, Chan BS.

Clin Toxicol (Phila). 2014 Apr;52(4):283-7. doi: 10.3109/15563650.2014.900179. Epub 2014 Mar 26.

PMID:
24666338
17.

Traumatic intracranial hemorrhage in patients taking dabigatran: report of 3 cases and review of the literature.

Wassef SN, Abel TJ, Grossbach A, Viljoen SV, Jackson AW, Howard MA 3rd, Greenlee JD.

Neurosurgery. 2013 Aug;73(2):E368-73; discussion E373-4. doi: 10.1227/01.neu.0000430763.95349.5f. Review.

PMID:
23670031
18.

Dabigatran: review of pharmacology and management of bleeding complications of this novel oral anticoagulant.

Ganetsky M, Babu KM, Salhanick SD, Brown RS, Boyer EW.

J Med Toxicol. 2011 Dec;7(4):281-7. doi: 10.1007/s13181-011-0178-y. Review.

19.

Dabigatran pharmacokinetics--implications for treatment.

Neuwirt H, Kronbichler A.

Am J Kidney Dis. 2013 Jul;62(1):180. doi: 10.1053/j.ajkd.2013.02.382. No abstract available.

PMID:
23773843
20.

Dabigatran and factor Xa inhibitors for stroke prevention in patients with nonvalvular atrial fibrillation.

Uchiyama S, Ibayashi S, Matsumoto M, Nagao T, Nagata K, Nakagawara J, Tanahashi N, Tanaka K, Toyoda K, Yasaka M.

J Stroke Cerebrovasc Dis. 2012 Apr;21(3):165-73. doi: 10.1016/j.jstrokecerebrovasdis.2012.01.011. Review.

PMID:
22440950

Supplemental Content

Support Center